Veradermics Logo

Veradermics

🇺🇸
MANE
US9229671048

Veradermics is a US clinical-stage biopharmaceutical company developing prescription therapies for dermatological conditions. Its pipeline focuses on treatments for androgenetic hair loss as well as other skin disorders such as warts.

Next Quarterly Earnings

Monday, March 29, 2027
Expected

Stock Price

Frequently asked questions

When did Veradermics last report quarterly earnings?

Veradermics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.58 USD.

How does Veradermics stock react to earnings?

Across its last 3 earnings reports, Veradermics stock moved by ±4.2% on average the following day. The largest reaction was -7.1% on 03/30/2026; 0 of 3 reactions were positive.

How do I add the Veradermics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Beat
Estimate:-$0.65
Actual:-$0.58
Difference:+$0.07
Price reaction (1 day):-1.6 %
Price reaction (7 days):+0.5 %
Q1 2026
Missed
Estimate:-$0.64
Actual:-$1.20
Difference:-$0.56
Price reaction (1 day):-3.9 %
Price reaction (7 days):-7.5 %
Q4 2025
Estimate:—
Actual:-$3.39
Price reaction (1 day):-7.1 %
Price reaction (7 days):-2.6 %

Earnings statistics

Stock reaction to earnings

±4.2%
Avg. next-day move
-7.1%
Largest move (03/30/2026)
0%
Share of positive reactions
±3.5%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Veradermics
Ticker Symbol
MANE
ISIN
US9229671048
Country
🇺🇸
USA
Sector
More Financial Information